Logo image of CLX

CLOROX COMPANY (CLX) Stock Fundamental Analysis

USA - NYSE:CLX - US1890541097 - Common Stock

118.69 USD
+0.33 (+0.28%)
Last: 10/16/2025, 9:49:21 AM
Fundamental Rating

5

Overall CLX gets a fundamental rating of 5 out of 10. We evaluated CLX against 12 industry peers in the Household Products industry. CLX scores excellent on profitability, but there are some minor concerns on its financial health. CLX is valied quite expensively at the moment, while it does show a decent growth rate. CLX also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CLX was profitable.
In the past year CLX had a positive cash flow from operations.
In the past 5 years CLX has always been profitable.
CLX had a positive operating cash flow in each of the past 5 years.
CLX Yearly Net Income VS EBIT VS OCF VS FCFCLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

The Return On Assets of CLX (14.57%) is better than 83.33% of its industry peers.
CLX has a better Return On Equity (252.34%) than 91.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 24.94%, CLX belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CLX is above the industry average of 15.56%.
The 3 year average ROIC (18.59%) for CLX is below the current ROIC(24.94%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 14.57%
ROE 252.34%
ROIC 24.94%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
CLX Yearly ROA, ROE, ROICCLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100 200 300 400

1.3 Margins

Looking at the Profit Margin, with a value of 11.40%, CLX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
CLX's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 17.09%, CLX is doing good in the industry, outperforming 66.67% of the companies in the same industry.
CLX's Operating Margin has declined in the last couple of years.
CLX's Gross Margin of 45.16% is fine compared to the rest of the industry. CLX outperforms 75.00% of its industry peers.
CLX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.09%
PM (TTM) 11.4%
GM 45.16%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
CLX Yearly Profit, Operating, Gross MarginsCLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLX is creating value.
Compared to 1 year ago, CLX has less shares outstanding
CLX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CLX has a worse debt to assets ratio.
CLX Yearly Shares OutstandingCLX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
CLX Yearly Total Debt VS Total AssetsCLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

An Altman-Z score of 3.70 indicates that CLX is not in any danger for bankruptcy at the moment.
CLX has a Altman-Z score of 3.70. This is comparable to the rest of the industry: CLX outperforms 58.33% of its industry peers.
The Debt to FCF ratio of CLX is 3.27, which is a good value as it means it would take CLX, 3.27 years of fcf income to pay off all of its debts.
CLX's Debt to FCF ratio of 3.27 is in line compared to the rest of the industry. CLX outperforms 58.33% of its industry peers.
CLX has a Debt/Equity ratio of 7.75. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 7.75, CLX is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 7.75
Debt/FCF 3.27
Altman-Z 3.7
ROIC/WACC3.19
WACC7.81%
CLX Yearly LT Debt VS Equity VS FCFCLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 0.84 indicates that CLX may have some problems paying its short term obligations.
CLX has a worse Current ratio (0.84) than 75.00% of its industry peers.
CLX has a Quick Ratio of 0.84. This is a bad value and indicates that CLX is not financially healthy enough and could expect problems in meeting its short term obligations.
CLX has a Quick ratio of 0.57. This is in the lower half of the industry: CLX underperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.57
CLX Yearly Current Assets VS Current LiabilitesCLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.08% over the past year.
The Earnings Per Share has been growing slightly by 1.01% on average over the past years.
CLX shows a small growth in Revenue. In the last year, the Revenue has grown by 0.16%.
The Revenue has been growing slightly by 1.11% on average over the past years.
EPS 1Y (TTM)25.08%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%57.69%
Revenue 1Y (TTM)0.16%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%4.47%

3.2 Future

CLX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.83% yearly.
The Revenue is expected to grow by 1.40% on average over the next years.
EPS Next Y-20.4%
EPS Next 2Y-5.02%
EPS Next 3Y-1.36%
EPS Next 5Y2.83%
Revenue Next Year-7.64%
Revenue Next 2Y-1.81%
Revenue Next 3Y-0.14%
Revenue Next 5Y1.4%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLX Yearly Revenue VS EstimatesCLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
CLX Yearly EPS VS EstimatesCLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.35, which indicates a correct valuation of CLX.
CLX's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of CLX to the average of the S&P500 Index (27.53), we can say CLX is valued slightly cheaper.
CLX is valuated rather expensively with a Price/Forward Earnings ratio of 19.29.
CLX's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of CLX to the average of the S&P500 Index (23.04), we can say CLX is valued inline with the index average.
Industry RankSector Rank
PE 15.35
Fwd PE 19.29
CLX Price Earnings VS Forward Price EarningsCLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLX is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 19.08
EV/EBITDA 11.72
CLX Per share dataCLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The decent profitability rating of CLX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)15.15
EPS Next 2Y-5.02%
EPS Next 3Y-1.36%

7

5. Dividend

5.1 Amount

CLX has a Yearly Dividend Yield of 4.13%, which is a nice return.
CLX's Dividend Yield is rather good when compared to the industry average which is at 3.07. CLX pays more dividend than 83.33% of the companies in the same industry.
CLX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 4.13%

5.2 History

The dividend of CLX has a limited annual growth rate of 2.88%.
CLX has paid a dividend for at least 10 years, which is a reliable track record.
CLX has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)2.88%
Div Incr Years34
Div Non Decr Years34
CLX Yearly Dividends per shareCLX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

CLX pays out 74.32% of its income as dividend. This is not a sustainable payout ratio.
The dividend of CLX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP74.32%
EPS Next 2Y-5.02%
EPS Next 3Y-1.36%
CLX Yearly Income VS Free CF VS DividendCLX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
CLX Dividend Payout.CLX Dividend Payout, showing the Payout Ratio.CLX Dividend Payout.PayoutRetained Earnings

CLOROX COMPANY

NYSE:CLX (10/16/2025, 9:49:21 AM)

118.69

+0.33 (+0.28%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryHousehold Products
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-29 2025-10-29/amc
Inst Owners91%
Inst Owner Change0.11%
Ins Owners0.24%
Ins Owner Change13.92%
Market Cap14.52B
Analysts54.81
Price Target140.29 (18.2%)
Short Float %6.06%
Short Ratio3.85
Dividend
Industry RankSector Rank
Dividend Yield 4.13%
Yearly Dividend4.88
Dividend Growth(5Y)2.88%
DP74.32%
Div Incr Years34
Div Non Decr Years34
Ex-Date10-22 2025-10-22 (1.24)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.21%
Min EPS beat(2)-8.29%
Max EPS beat(2)28.7%
EPS beat(4)3
Avg EPS beat(4)15.39%
Min EPS beat(4)-8.29%
Max EPS beat(4)32.02%
EPS beat(8)7
Avg EPS beat(8)64.51%
EPS beat(12)11
Avg EPS beat(12)54.3%
EPS beat(16)13
Avg EPS beat(16)42.35%
Revenue beat(2)1
Avg Revenue beat(2)-1.36%
Min Revenue beat(2)-4.3%
Max Revenue beat(2)1.58%
Revenue beat(4)3
Avg Revenue beat(4)1.53%
Min Revenue beat(4)-4.3%
Max Revenue beat(4)6.21%
Revenue beat(8)5
Avg Revenue beat(8)1.62%
Revenue beat(12)9
Avg Revenue beat(12)2.33%
Revenue beat(16)11
Avg Revenue beat(16)1.85%
PT rev (1m)-0.68%
PT rev (3m)-7.26%
EPS NQ rev (1m)-0.96%
EPS NQ rev (3m)-40.83%
EPS NY rev (1m)0.01%
EPS NY rev (3m)-8.81%
Revenue NQ rev (1m)-0.21%
Revenue NQ rev (3m)-12.09%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-5.87%
Valuation
Industry RankSector Rank
PE 15.35
Fwd PE 19.29
P/S 2.04
P/FCF 19.08
P/OCF 14.8
P/B 45.22
P/tB N/A
EV/EBITDA 11.72
EPS(TTM)7.73
EY6.51%
EPS(NY)6.15
Fwd EY5.18%
FCF(TTM)6.22
FCFY5.24%
OCF(TTM)8.02
OCFY6.76%
SpS58.08
BVpS2.62
TBVpS-12.05
PEG (NY)N/A
PEG (5Y)15.15
Profitability
Industry RankSector Rank
ROA 14.57%
ROE 252.34%
ROCE 33.33%
ROIC 24.94%
ROICexc 26.14%
ROICexgc 54%
OM 17.09%
PM (TTM) 11.4%
GM 45.16%
FCFM 10.71%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
ROICexc(3y)19.75%
ROICexc(5y)18.87%
ROICexgc(3y)40.28%
ROICexgc(5y)41.99%
ROCE(3y)24.92%
ROCE(5y)23.9%
ROICexcg growth 3Y25.21%
ROICexcg growth 5Y-4.26%
ROICexc growth 3Y28.43%
ROICexc growth 5Y1.01%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
F-Score7
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 7.75
Debt/FCF 3.27
Debt/EBITDA 1.74
Cap/Depr 100.46%
Cap/Sales 3.1%
Interest Coverage 12.52
Cash Conversion 68.46%
Profit Quality 93.95%
Current Ratio 0.84
Quick Ratio 0.57
Altman-Z 3.7
F-Score7
WACC7.81%
ROIC/WACC3.19
Cap/Depr(3y)95.76%
Cap/Depr(5y)111.24%
Cap/Sales(3y)3.06%
Cap/Sales(5y)3.44%
Profit Quality(3y)296.87%
Profit Quality(5y)227.9%
High Growth Momentum
Growth
EPS 1Y (TTM)25.08%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%57.69%
EPS Next Y-20.4%
EPS Next 2Y-5.02%
EPS Next 3Y-1.36%
EPS Next 5Y2.83%
Revenue 1Y (TTM)0.16%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%4.47%
Revenue Next Year-7.64%
Revenue Next 2Y-1.81%
Revenue Next 3Y-0.14%
Revenue Next 5Y1.4%
EBIT growth 1Y27.25%
EBIT growth 3Y18.51%
EBIT growth 5Y-1.39%
EBIT Next Year6.95%
EBIT Next 3Y7.21%
EBIT Next 5Y6.75%
FCF growth 1Y57.56%
FCF growth 3Y12.46%
FCF growth 5Y-10.05%
OCF growth 1Y41.15%
OCF growth 3Y7.67%
OCF growth 5Y-8.7%